Part 3 of a four part series on cellular glucose transporters, SGLT1/SGLT2 inhibition, and cellular energetics related to cardiovascular disease and heart failure. This installment explores the development of cardiovascular disease at the physiological level, and explains the connection between energy homeostasis and the progression of atherosclerosis.